Medtronic plc. MDT recently made a major development in the field of diabetes management. The company reached an outcome-based agreement with Blue Cross and Blue Shield of Minnesota in relation to the ...

DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...

Back in the day – roughly around 2007, Medtronic offered a standalone continuous glucose monitoring system where diabetics who were not using a Medtronic insulin pump could use it to get continuous ...

Medtronic has received a CE Mark for its Guardian Connect mobile continuous glucose monitor (CGM) and app. The company will begin selling the system in select countries in Europe, Asia, and Latin ...

Sugar.IQ — the digital diabetes assistant for Guardian Connect system users that is jointly supported by Medtronic and IBM Watson — has a new feature that uses artificial intelligence to predict ...

Medtronic’s Guardian Connect continuous glucose monitoring system earned FDA approval March 12. Here are four things to know. 1. The Guardian Connect system uses predictive analytics and artificial ...

Users also have access to the Company's Sugar.IQ app, which uses IBM's Watson Health platform, to identify glucose patterns based on factors that may affect them (ie, food intake, insulin dosages, ...

Medtronic’s CEO, Omar Ishrak, has long expressed a desire to expand the Irish medtech company’s footprint into the much larger type 2 diabetes market. And over the years, the company has made strides ...

Medtronic plc has reported the launch of the Inpen integrated with real-time Guardian Connect continuous glucose monitoring (CGM) data. Inpen is the first U.S. FDA-cleared smart insulin pen on the ...

Medtronic and IBM have data showing that the combination of a continuous glucose monitoring system and Suger.IQ app enables diabetics to stay their time in optimal glycemic range for an extra hour a ...

The US Food and Drug Administration has approved a new stand-alone continuous glucose monitoring (CGM) system, Medtronic's Guardian Connect, that alerts users to impending high and low blood glucose ...